Literature DB >> 2763269

Protein C assays in uremia.

P J Sørensen1, F Knudsen, A H Nielsen, J Dyerberg.   

Abstract

Protein C was determined in 42 patients with terminal uremia and 20 healthy controls in three different ways 1) anticoagulant activity 2) amidolytic activity 3) antigen level. Protein C anticoagulant activity was markedly decreased in uremia, but was partly normalized during hemodialysis treatment, whereas the amidolytic activity and antigen level of protein C were normal and without changes during dialysis. The activities and antigen levels of factor II and X were normal before and after hemodialysis. In anticoagulated patients we found a good correlation between prothrombin levels and protein C levels determined with three different assays. We did not find any evidence for a defect carboxylation of protein C as the cause for the defective protein C in uremia. The BaCl2 precipitation in the Protein C anticoagulant assay was incomplete both in uremia and in controls but without differences between the two groups. In vitro addition of urea and creatinine did not decrease protein C activity. The cause of the defective protein C in uremia is still not known but it might contribute to thromboembolic complications.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2763269     DOI: 10.1016/0049-3848(89)90088-1

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  6 in total

1.  Hemostatic Factors, APOL1, and ESRD Risk: Another Piece of the Puzzle?

Authors:  Walter G Wasser; Etty Kruzel-Davila
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-17       Impact factor: 8.237

2.  Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.

Authors:  Adrienne Tin; Morgan E Grams; Nisa M Maruthur; Brad C Astor; David Couper; Thomas H Mosley; Myriam Fornage; Rulan S Parekh; Josef Coresh; Wen Hong Linda Kao
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-17       Impact factor: 8.237

3.  Extrahepatic expression and regulation of protein C in the mouse.

Authors:  K Yamamoto; D J Loskutoff
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

4.  Coagulation inhibitors and fibrinolytic parameters in patients on peritoneal dialysis and haemodialysis.

Authors:  J Alwakeel; A M Gader; S Hurieb; A K al-Momen; A Mitwalli; H Abu Aisha
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

5.  Monocyte expression of tissue factor and adhesion molecules: the link with accelerated coronary artery disease in patients with chronic renal failure.

Authors:  N M Al-Saady; E W Leatham; S Gupta; J T Kwan; J B Eastwood; C A Seymour
Journal:  Heart       Date:  1999-02       Impact factor: 5.994

6.  Protein C inhibitor is expressed in tubular cells of human kidney.

Authors:  K P Radtke; J A Fernández; J S Greengard; W W Tang; C B Wilson; D J Loskutoff; I Scharrer; J H Griffin
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.